SPIRONOLACTONE

Clinical Indication

Oedema in heart failure, hypertension and reduction of hypokalaemia induced by diuretics in children.

Comments

In line with SCA: Paediatric Cardiology Medications

Date of classification

December 2013

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.